Acquisitions, Investments, and Licenses - Summary of Assets Acquired and Liabilities Assumed (Details) (USD $)
|
Jun. 30, 2014
|
Dec. 31, 2013
|
Mar. 31, 2013
OPKO Renal
|
Mar. 31, 2013
OPKO Renal
Patents
|
Mar. 31, 2013
OPKO Renal
In process research and development
|
Aug. 31, 2013
OPKO Biologics
|
Aug. 31, 2013
OPKO Biologics
Patents
|
Aug. 31, 2013
OPKO Biologics
In process research and development
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Business Acquisition [Line Items] | ||||||||||||||||
Current assets | $ 1,224,000 | [1] | $ 21,500,000 | [1] | ||||||||||||
Intangible assets: | ||||||||||||||||
In-process research and development | 191,530,000 | 590,200,000 | ||||||||||||||
Patents | 210,000 | 0 | ||||||||||||||
Total intangible assets | 191,740,000 | 590,200,000 | ||||||||||||||
Goodwill | 226,001,000 | [2] | 226,373,000 | [2] | 2,411,000 | 139,784,000 | ||||||||||
Property, plant and equipment | 306,000 | 1,057,000 | ||||||||||||||
Other assets | 0 | 371,000 | ||||||||||||||
Accounts payable and accrued expenses | (1,069,000) | (9,866,000) | ||||||||||||||
Deferred tax liability | 0 | (156,403,000) | ||||||||||||||
Total purchase price | 194,612,000 | 586,643,000 | ||||||||||||||
Current Asset include cash | $ 400,000 | $ 20,500,000 | ||||||||||||||
|